GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Tatva Chintan Pharma Chem Ltd (BOM:543321) » Definitions » Price-to-Owner-Earnings

Tatva Chintan Pharma Chem (BOM:543321) Price-to-Owner-Earnings : 164.81 (As of May. 25, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Tatva Chintan Pharma Chem Price-to-Owner-Earnings?

As of today (2024-05-25), Tatva Chintan Pharma Chem's share price is ₹1097.65. Tatva Chintan Pharma Chem's Owner Earnings per Share (TTM) ended in Mar. 2024 was ₹6.66. It's Price-to-Owner-Earnings for today is 164.81.


The historical rank and industry rank for Tatva Chintan Pharma Chem's Price-to-Owner-Earnings or its related term are showing as below:

BOM:543321' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 164.95   Med: 186.11   Max: 192.83
Current: 164.95

During the past 6 years, the highest Price-to-Owner-Earnings of Tatva Chintan Pharma Chem was 192.83. The lowest was 164.95. And the median was 186.11.


BOM:543321's Price-to-Owner-Earnings is ranked worse than
92.77% of 705 companies
in the Chemicals industry
Industry Median: 19.02 vs BOM:543321: 164.95

As of today (2024-05-25), Tatva Chintan Pharma Chem's share price is ₹1097.65. Tatva Chintan Pharma Chem's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹13.33. Therefore, Tatva Chintan Pharma Chem's PE Ratio for today is 82.34.

As of today (2024-05-25), Tatva Chintan Pharma Chem's share price is ₹1097.65. Tatva Chintan Pharma Chem's EPS without NRI for the trailing twelve months (TTM) ended in was ₹13.33. Therefore, Tatva Chintan Pharma Chem's PE Ratio without NRI for today is 82.34.

During the past 6 years, Tatva Chintan Pharma Chem's highest PE Ratio without NRI was 105.17. The lowest was 46.98. And the median was 70.60.


Tatva Chintan Pharma Chem Price-to-Owner-Earnings Historical Data

The historical data trend for Tatva Chintan Pharma Chem's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tatva Chintan Pharma Chem Price-to-Owner-Earnings Chart

Tatva Chintan Pharma Chem Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Owner-Earnings
Get a 7-Day Free Trial - - - - 162.00

Tatva Chintan Pharma Chem Quarterly Data
Mar19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 162.00

Competitive Comparison of Tatva Chintan Pharma Chem's Price-to-Owner-Earnings

For the Specialty Chemicals subindustry, Tatva Chintan Pharma Chem's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tatva Chintan Pharma Chem's Price-to-Owner-Earnings Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Tatva Chintan Pharma Chem's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Tatva Chintan Pharma Chem's Price-to-Owner-Earnings falls into.



Tatva Chintan Pharma Chem Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Tatva Chintan Pharma Chem's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=1097.65/6.66
=164.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tatva Chintan Pharma Chem  (BOM:543321) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Tatva Chintan Pharma Chem Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Tatva Chintan Pharma Chem's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Tatva Chintan Pharma Chem (BOM:543321) Business Description

Traded in Other Exchanges
Address
Plot No. 353, Makarpura GIDC, Vadodara, GJ, IND, 390010
Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.

Tatva Chintan Pharma Chem (BOM:543321) Headlines

No Headlines